Filing Details

Accession Number:
0001179110-18-014063
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-18 16:36:20
Reporting Period:
2018-12-10
Accepted Time:
2018-12-18 16:36:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761799 Mark Timney 8 Sylvan Way
Parsippany NJ 07054
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-17 26,863 $18.60 26,863 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Acquisiton 2018-12-10 450,000 $0.00 450,000 $20.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
450,000 2028-12-10 No 4 A Direct
Footnotes
  1. Represents the weighted average purchase price of the shares purchased ranging from a low of $17.87 to a high of $19.17 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. This option vests 25% on December 10, 2019 and in thirty-six equal monthly installments thereafter.